PTGS2 and colorectal cancer: It has been reported that using either aspirin or celecoxib, which inhibit cyclooxygenase-2 (COX-2), can reduce the risk of colorectal cancer in high-risk groups, such as obese individuals and those who smoke and lack physical exercise [2,3].